BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 28350323)

  • 1. Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus.
    Perez-Hernandez J; Redon J; Cortes R
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28350323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles mediate intercellular communication: Transfer of functionally active microRNAs by microvesicles into phagocytes.
    Claßen L; Tykocinski LO; Wiedmann F; Birr C; Schiller P; Tucher C; Krienke S; Raab MS; Blank N; Lorenz HM; Schiller M
    Eur J Immunol; 2017 Sep; 47(9):1535-1549. PubMed ID: 28665018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicles as Biomarkers of Systemic Lupus Erythematosus.
    Perez-Hernandez J; Cortes R
    Dis Markers; 2015; 2015():613536. PubMed ID: 26435565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Vesicles in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Functions and Applications.
    Zhang B; Zhao M; Lu Q
    Front Immunol; 2020; 11():575712. PubMed ID: 33519800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cell derived extracellular vesicles as a therapeutic tool: immune regulation, MSC priming, and applications to SLE.
    Wong C; Stoilova I; Gazeau F; Herbeuval JP; Fourniols T
    Front Immunol; 2024; 15():1355845. PubMed ID: 38390327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Progress in Treating Systemic Lupus Erythematosus Using Exosomes/MicroRNAs.
    Liu YJ; Miao HB; Lin S; Chen Z
    Cell Transplant; 2023; 32():9636897221148775. PubMed ID: 36661068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles Tune the Immune System in Renal Disease: A Focus on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, Thrombotic Microangiopathy and ANCA-Vasculitis.
    Mazzariol M; Camussi G; Brizzi MF
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles and Their Potential as Novel Immunomodulatory Therapeutic Agents.
    Börger V; Bremer M; Ferrer-Tur R; Gockeln L; Stambouli O; Becic A; Giebel B
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28684664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effects of extracellular vesicles from mesenchymal stromal cells: Implication for therapeutic approach in autoimmune diseases.
    Liao HJ; Hsu PN
    Kaohsiung J Med Sci; 2024 Jun; 40(6):520-529. PubMed ID: 38712483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications.
    Zhao Y; Wei W; Liu ML
    J Autoimmun; 2020 Dec; 115():102540. PubMed ID: 32893081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Therapeutic Application and Mechanism of Action of Stem Cell-Derived Extracellular Vesicles (EVs) in Systemic Lupus Erythematosus (SLE).
    Rajeev Kumar S; Sakthiswary R; Lokanathan Y
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of T Cell Activation and Differentiation by Extracellular Vesicles and Their Pathogenic Role in Systemic Lupus Erythematosus and Multiple Sclerosis.
    Ulivieri C; Baldari CT
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28157168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Development of Mesenchymal Stem Cells or Their Extracellular Vesicles to Inhibit Autoimmune-Mediated Inflammatory Processes in Systemic Lupus Erythematosus.
    Sharma J; Hampton JM; Valiente GR; Wada T; Steigelman H; Young MC; Spurbeck RR; Blazek AD; Bösh S; Jarjour WN; Young NA
    Front Immunol; 2017; 8():526. PubMed ID: 28539924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
    El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
    Front Immunol; 2021; 12():643170. PubMed ID: 33732263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of extracellular vesicles in autoimmune diseases.
    Turpin D; Truchetet ME; Faustin B; Augusto JF; Contin-Bordes C; Brisson A; Blanco P; Duffau P
    Autoimmun Rev; 2016 Feb; 15(2):174-83. PubMed ID: 26554931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory Effect of MSCs and MSCs-Derived Extracellular Vesicles in Systemic Lupus Erythematosus.
    Yang C; Sun J; Tian Y; Li H; Zhang L; Yang J; Wang J; Zhang J; Yan S; Xu D
    Front Immunol; 2021; 12():714832. PubMed ID: 34603289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.
    Doeppner TR; Herz J; Görgens A; Schlechter J; Ludwig AK; Radtke S; de Miroschedji K; Horn PA; Giebel B; Hermann DM
    Stem Cells Transl Med; 2015 Oct; 4(10):1131-43. PubMed ID: 26339036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicles in Angiogenesis.
    Todorova D; Simoncini S; Lacroix R; Sabatier F; Dignat-George F
    Circ Res; 2017 May; 120(10):1658-1673. PubMed ID: 28495996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases.
    Sharabi A; Mozes E
    Immunotherapy; 2009 May; 1(3):385-401. PubMed ID: 20635958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles in Chronic Obstructive Pulmonary Disease.
    Kadota T; Fujita Y; Yoshioka Y; Araya J; Kuwano K; Ochiya T
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.